The Role of NAD+ IV Hydration Therapy in Managing Eczema and Psoriasis
NAD+ (Nicotinamide Adenine Dinucleotide) IV hydration therapy has emerged as a promising tool for improving cellular health and addressing chronic inflammatory conditions. Its potential benefits extend to managing eczema and psoriasis—two conditions characterized by inflammation, immune system dysfunction, and compromised skin health. Let’s explore how NAD+ therapy works and its impact on these skin disorders.
What Is NAD+ IV Therapy?
NAD+ is a coenzyme essential for energy production, DNA repair, and reducing oxidative stress. Declining NAD+ levels, often linked to aging, stress, and chronic illnesses, can exacerbate inflammation and impair cellular repair mechanisms. Administered intravenously, NAD+ bypasses the digestive system for direct absorption into the bloodstream, enhancing its therapeutic effects.
How NAD+ Supports Eczema and Psoriasis Treatment
1. Regulates Inflammation:
Eczema and psoriasis are driven by chronic inflammation and immune dysregulation. NAD+ boosts the activity of enzymes called sirtuins, which are known to reduce inflammatory signaling pathways and support cellular repair processes. Research shows that sirtuins play a critical role in mitigating skin inflammation and promoting tissue homeostasis (Kanherkar et al., 2014).
2. Enhances Skin Barrier Function:
A damaged skin barrier is a hallmark of eczema and psoriasis, leaving the skin vulnerable to irritation and infection. NAD+ supports keratinocyte function, essential for maintaining the structural integrity of the skin barrier (Verdin et al., 2014).
3. Stimulates Skin Regeneration:
Psoriasis is characterized by the rapid turnover of skin cells. NAD+ aids in DNA repair and supports healthy cell division, ensuring that new skin cells are properly formed. This can help reduce the appearance of plaques and improve skin texture (Braidy et al., 2011).
4. Reduces Oxidative Stress:
Oxidative stress is a key contributor to flare-ups of eczema and psoriasis. NAD+ enhances the activity of antioxidants within the body, neutralizing free radicals and reducing oxidative damage to the skin (Yoshino et al., 2018).
The Science Behind NAD+ Therapy
Studies suggest that NAD+ plays a central role in inflammatory regulation. For instance, Verdin et al. (2014) found that NAD+ metabolism directly influences sirtuin activity, which governs inflammation and cellular health. Additionally, research has shown that replenishing NAD+ levels can reduce markers of oxidative stress and inflammation in both acute and chronic conditions.
What to Expect from NAD+ IV Therapy
During an NAD+ IV session, the coenzyme is delivered directly into your bloodstream. Each session typically lasts 1–2 hours, and many clients report improvements in energy, skin health, and overall well-being after a few treatments. It is important to note that while NAD+ therapy can complement traditional eczema and psoriasis treatments, it should be used as part of a comprehensive care plan tailored to individual needs.
Is NAD+ IV Therapy Right for You?
While more clinical studies are needed specifically on NAD+ for eczema and psoriasis, the therapy’s proven ability to reduce inflammation and support cellular repair makes it a promising option for managing these conditions. Speak with your healthcare provider or a licensed practitioner to determine if NAD+ therapy fits your treatment plan.
If your'e interested in exploring NAD+ IV hydration therapy to improve your skin health and overall well-being, we're excited to offer 15% off your first session. Simply use the discount code NADV24 when booking your appointment.
References:
• Braidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., & Sachdev, P. (2011). Role of NAD+ and related precursors as therapeutic targets for age-related degenerative diseases: Rationale, biochemistry, pharmacokinetics, and outcomes. Antioxidants & Redox Signaling, 19(17), 1–20.
• Kanherkar, R. R., Bhatia-Dey, N., & Csoka, A. B. (2014). Epigenetics across the human lifespan. Frontiers in Cellular and Developmental Biology, 2, 49.
• Verdin, E., Hirschey, M. D., Finley, L. W., & Haigis, M. C. (2014). Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends in Biochemical Sciences, 39(12), 1–9.
• Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metabolism, 27(3), 513–528.
Commentaires